Evidence map›Paper›PMID 41200221›Full record

ArticleFrontiers in psychiatry2025

Clinical phenotypes of psychosis and reoffending risk among justice-involved adolescents: a population-based cohort study.

Emaediong I Akpanekpo, Tony Butler

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emaediong I AkpanekpoSchool of Population Health, The University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.
Tony ButlerSchool of Population Health, The University of New South Wales (UNSW) Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High reoffending rates among justice-involved adolescents necessitate identifying modifiable risk factors. Given the elevated prevalence of psychosis in this group compared to the general adolescent population, determining its contribution requires differentiation by clinical phenotypes and quantification of associated risk. This study aimed to determine the association between clinical phenotypes of psychosis and reoffending among justice-involved adolescents. Method: We conducted a retrospective cohort study using linked administrative health and justice data (2001-2021) from New South Wales, Australia. Justice-involved adolescents (10-17 years) with a diagnosed psychotic disorder identified from hospital/emergency records (n=236) were matched (approx. 1:3) on age, sex, and index offense year to controls without psychosis (n=679). Time to first general and violent reoffending conviction within 24 months was analyzed using stratified Cox proportional hazards models, adjusting for confounders. Results: Compared to controls, schizophrenia-related psychosis was significantly associated with increased hazards of general reoffending (adjusted Hazard Ratio [aHR]=1.51, 95% CI: 1.10-2.07) and violent reoffending (aHR=2.71, 95% CI: 1.87-3.94). Substance-induced psychosis also showed significantly increased hazards for general reoffending (aHR=3.09, 95% CI: 1.73-5.50) and violent reoffending (aHR=2.87, 95% CI: 1.49-5.56). Conclusions: Non-affective psychoses significantly elevate reoffending risk among justice-involved adolescents, with different magnitudes of risk associated with schizophrenia-related and substance-induced psychosis. Findings highlight the need for nuanced risk assessment and targeted strategies, including routine screening, early intervention, and integrated care pathways within the youth justice system.

Indexed as

adolescentspsychosisrecidivismreoffendingschizophrenia

Identifiers

PMID41200221
PMCPMC12586121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.